Susquehanna International Group’s Artelo Biosciences ARTL Stock Holding History

Susquehanna International Group’s Portfolio ARTL Stock Details ARTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,133	Closed	-$17.8K	–	12603
2025 Q1	$17.8K	Buy	+1,133	New	+$22.8K	﹤0.01%	12133
2022 Q3	–	Sell	-297	Closed	-$25K	–	13111
2022 Q2	$25K	Buy	297 +257	+643%	+$25.3K	﹤0.01%	12295
2022 Q1	$5K	Sell	40 -20	-33%	-$2.3K	﹤0.01%	12816
2021 Q4	$8K	Buy	+60	New	+$11.9K	﹤0.01%	12951

Other funds holding ARTL

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Susquehanna International Group's ARTL Position: Q2 2025 in Review

Susquehanna International Group sold out of Artelo Biosciences (ARTL) in Q2 2025, closing a stake of 1,133 shares — an estimated $17.8K sold.

Susquehanna International Group first reported a position in ARTL in Q4 2021 and held it in 4 quarters. The position peaked at $25K in Q2 2022. 6 funds tracked by Wall St. Rank hold ARTL as of Q2 2025.

Susquehanna International Group reported no remaining Artelo Biosciences position as of Q2 2025 after selling out during the quarter.
Susquehanna International Group sold 1,133 Artelo Biosciences shares in Q2 2025, an estimated $17.8K.
Susquehanna International Group first reported a position in Artelo Biosciences in Q4 2021 and held it in 4 quarters.
Susquehanna International Group's Artelo Biosciences position peaked at $25K in Q2 2022.
6 funds tracked by Wall St. Rank held Artelo Biosciences as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.